Annual Report
Read the message from the chair and learn more about advances in care in this year's annual report.
Learn more about new initiatives in clinical care, research and education across our 10 divisions in FY26.
The Department of Medicine has experienced remarkable growth, with every division advancing our tripartite mission of clinical care, research, and education. This collective progress translates into better patient care, meaningful scientific discovery, and the development of the next generation of outstanding leaders in medicine.
Led by Thomas Di Salvo, M.D., MPH, MBA, the Division of Cardiology continues to strengthen its clinical, research, and educational impact regionally and nationally. In FY26, the division welcomed five new faculty — Matthew Belanger, M.D. (General Cardiology); Swati Rao, M.D., and Rory Dowd, M.D. (Electrophysiology); Payton Kendsersky, M.D. (Interventional); and Kurt Prins, M.D., Ph.D. (General Cardiology) — with six more joining in FY27. Dr. Prins also became Director of the Gazes Cardiac Research Institute, one of the nation's leading heart failure research centers, where investigators bridge basic science and clinical practice using single-cell biology, proteomics, metabolomics, and genetic analysis. In his first year, Dr. Prins and the Gazes team increased research funding, published high-impact manuscripts, and forged new collaborations.
As one of the Southeast's top-rated cardiovascular centers, the MUSC Health Heart & Vascular Center delivers comprehensive, patient-centered care through nationally recognized physicians and advanced technology.
Led by Marc-Andre Cornier, M.D., the Division of Endocrinology, Diabetes, and Metabolic Diseases is renowned for its patient-centered care, groundbreaking research, and commitment to education. Our multidisciplinary clinics provide comprehensive diagnostic and treatment services for a wide range of endocrine disorders, including diabetes, obesity, and thyroid, pituitary, adrenal and lipid disorder, reaching patients across South Carolina.
Focused on strategic growth, the division has welcomed new faculty and advanced practice providers, expanding clinics across the state and enhancing services in cardiometabolic health. For over five decades, our internationally recognized faculty have driven transformative research, setting new standards in endocrine, diabetes and metabolic care and continuing to lead advancements on a global scale.
Additional highlights include:
Visit the Division of Endocrinology, Diabetes, and Metabolic Diseases' website
Under the leadership of Garth Swanson, M.D., the MUSC Division of Gastroenterology and Hepatology has achieved significant growth in clinical care, research, and education over the past three years. The division has expanded its faculty and staff to meet the needs of a rapidly growing community, driving increases in clinical volume and colorectal cancer screenings. The Liver Transplant Program has strengthened its national standing with a notable rise in transplant volume, while the motility program broadened diagnostic services for patients with complex gastrointestinal disorders.
In FY26, the division welcomed seven new faculty members across general gastroenterology, motility, transplant hepatology, and interventional endoscopy, with three additional recruits set to join in FY27. Research remains a central pillar of the division’s mission, anchored by the COBRE in Digestive and Liver Disease and the NIDDK P30-funded Digestive Disease Research Core Center.
The division also expanded fellowship training, including its advanced inflammatory bowel disease fellowship, to prepare the next generation of specialists.
Under the leadership of Kimberly Davis, M.D., FACP, the Division of General Internal Medicine, Geriatrics, and Palliative Care continues to advance clinical excellence, education, and research across the Department of Medicine. With more than 40 clinical and research faculty, the division provides broad inpatient and outpatient training for residents and fellows while mentoring trainees in clinical care, quality, value-based care, and research.
Strategic recruitment continues to expand the division’s reach, with eight physicians joining in FY26 and two additional recruits scheduled for FY27. Through innovation in primary care, geriatrics, palliative medicine, and sickle cell care, the division remains committed to improving outcomes across South Carolina and beyond.
General Internal Medicine:
Geriatrics:
Sickle Cell:
Palliative Care:
Visit the Division of General Internal Medicine, Geriatrics, and Palliative Care
Under the leadership of Craig Lockhart, M.D., MHS, the Division of Hematology and Oncology continued to earn national and international recognition in FY26 for its contributions to clinical care, research, and education. As an integral part of Hollings Cancer Center, South Carolina's only National Cancer Institute-designated cancer center, the division grew its faculty and expanded the scope of its clinical and research initiatives. Russell Jenkins, M.D., Ph.D.; Mohammad Alhousani, M.D.; and Priyal Agarwal, M.D., joined the division in FY26, following eight faculty recruits in FY25. Four additional faculty members are scheduled to join in FY27. The division also leads the state's only combined hematology and oncology fellowship and advances new treatments through clinical trials and laboratory discoveries.
Under the leadership of Marc Heincelman, M.D., MPH, SFHM, the Division of Hospital Medicine's 56 physicians and 11 APPs provide care to patients on 14 inpatient services, one orthopedic co-management service, one consult service, and a robust preoperative medicine clinic, while providing tele-hospitalist support to four small rural hospitals in South Carolina. The division leads innovation in patient care, education, and research to meet the needs of patients across South Carolina and beyond. In FY26, the division welcomed eight new faculty members, with three more recruits set to join in FY27.
Division faculty are advancing research that improves clinical care and expands educational opportunities.
Division faculty play a central role in undergraduate and graduate medical education at MUSC, leading key initiatives in point-of-care ultrasound training, patient mobility, and clinical competency evaluation. This year, several were recognized for education leadership at the division, MUSC College of Medicine, and national levels:
Under the leadership of Cassandra Salgado, M.D., MS, the Division of Infectious Diseases excels in patient care, research, and education. Faculty provide consultative and ambulatory care across South Carolina and lead key MUSC programs in global health, infection prevention, antimicrobial stewardship, outpatient antimicrobial therapy (OPAT), telehealth, and transplant infectious diseases. In FY26, the division welcomed Nikko Tabliago, M.D., with Sean Tyler, M.D., and Zach Gruss, PharmD., joining in FY27.
For more than 30 years, the division has delivered comprehensive HIV care through the HRSA and SC DHEC Ryan White Program, with research spanning HIV/AIDS, tuberculosis, nontuberculous mycobacteria (NTM), antimicrobial resistance, hepatitis, OPAT, and transplant infectious diseases. Faculty also lead educational programs locally and nationally while serving in major institutional leadership roles that strengthen MUSC’s clinical, research, and public health impact.
The Division of Nephrology advances the understanding and treatment of kidney disease through excellence in clinical care, research, and education. Under the guidance of Division Director Josh Lipschutz, M.D., and Clinical Director Ruth Campbell, M.D., the past year has been marked by significant accomplishments across all three missions. Strategic recruitment continues to expand the division's reach, with two physicians joining in FY26 and four additional recruits — three in nephrology transplant and one in general nephrology — scheduled for FY27. With 29 faculty members recognized for their national prominence, the division continues to excel in providing top-tier patient care, groundbreaking research, and comprehensive training for future nephrologists.
Under the leadership of Dee Ford, M.D., MSCR, the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine expanded access to specialized care, strengthened its research portfolio and increased fellowship training in FY26. Clinical teams introduced a new treatment for chronic blood clots in the lungs, improved access to sleep care and broadened lung cancer screening across South Carolina. Faculty also led national and international research in critical care, thoracic oncology, sarcoidosis and bronchiectasis.
Strategic recruitment continues to expand the division's reach, with four physicians joining in FY26 and five additional recruits scheduled for FY27. Growth in pulmonary and critical care, sleep medicine and interventional pulmonology fellowships further reinforced the division's commitment to preparing the next generation of specialists while improving care for patients with complex respiratory conditions.
Visit the Division of Pulmonary, Critical Care, Allergy & Sleep Medicine's website
Under the leadership of Jim Oates, M.D., the Division of Rheumatology and Immunology expanded its clinical, research and education programs in FY26. Over the past two years, Sean Carter, M.D.; Jessica English, M.D., MSCR; Anne Maitland, M.D.; Priyanka Ballal, M.D.; and Silera Holguin Balbuena, M.D., joined the division, adding expertise in clinical ultrasound, lupus, reproductive rheumatology, Ehlers-Danlos syndrome and mast cell disorders. Faculty continued to advance care and research in lupus, systemic sclerosis, vasculitis and other complex autoimmune diseases while collaborating with Pediatric Rheumatology. The National Scleroderma Foundation also designated MUSC as South Carolina's only Scleroderma Research and Treatment Center.
In FY26, faculty secured nearly $2 million in new research funding, published 57 original manuscripts, one book and one book chapter, and funded five pilot projects through the P30 Core Center for Clinical Research program.
Faculty secured multiple competitive awards this year, including:
MUSC Department of Medicine 2026 Annual Report
Read the message from the chair and learn more about advances in care in this year's annual report.
This was a year of substantial growth and expansion.
This year has been one of remarkable growth and continued excellence in medical education.
The Department of Medicine is fostering a culture where every team member feels valued, respected, and empowered to contribute.
Philanthropy transforms gratitude into progress, empowering groundbreaking research, advancing discoveries and care, and bringing hope for better outcomes to patients and families.
Learn more about the recent advances in basic, clinical and translational research.
This year, several faculty members assumed key leadership roles across the broader university and health system.